glp-1 drug market size share of RAs in 2016 and 2017 Market insights: How to analyze
Description
However, the reduction in HbA1c was non-significantly diminished with exenatide twice-daily in the small subset of patients (5%) with higher titers
And its use continues to make history
The only side effect that Zarghamis doctor had warned her about was pancreatitis
Furthermore, they also found that 'a balanced dual agonist in mice engineered to lack GLP-1 receptors still induced weight loss, proving that the compounds were not causing weight loss purely by targeting GLP-1' (Molteni, Chen)
